1-3 of 3
Tohru Masaoka
Close
Sort by
Journal Articles

Cefozoplan, Meropenem, or Imipenem-Cilastatin Versus Cefepime As an Empirical Therapy in High Risk Febrile Neutropenic Adult Patients: A Multicenter Prospective Randomized Trial

Takahiko Nakane, MD, PhD, Toshiharu Tamaki, Kazuo Tamura, MD, PhD, Isao Yoshida, MD, Toshihiro Fukushima, MD, PhD, Yoichi Tatsumi, MD, PhD, Yasunori Nakagawa, MD, Kazuo Hatanaka, MD, Tsutomu Takahashi, MD, PhD, Nobu Akiyama, MD, PhD, Mitsune Tanimoto, MD, PhD, Kazuma Ohyashiki, MD, PhD, Akio Urabe, MD, PhD, Tohru Masaoka, MD, PhD, Akihisa Kanamaru, MD, PhD
Journal: Blood
Blood (2012) 120 (21): 1037.
https://doi.org/10.1182/blood.V120.21.1037.1037
Published: 2012
Journal Articles

Efficacy and Safety of Micafungin as An Empirical Antifungal Therapy for Suspected Fungal Infection in Patients with Hematological Disorders.

Minoru Yoshida, Kazuo Tamura, Masahiro Imamura, MD, Yoshiro Niitsu, Takeshi Sasaki, Akio Urabe, Kazuma Ohyashiki, Tomoki Naoe, Akihisa Kanamaru, Mitsune Tanimoto, Tohru Masaoka
Journal: Blood
Blood (2008) 112 (11): 1939.
https://doi.org/10.1182/blood.V112.11.1939.1939
Published: 2008
Journal Articles

Efficacy and Safety of Micafungin, an Echinocandin Antifungal Agent on Systemic Fungal Infections in Patients with Hematological Disorders.

Kazuo Tamura, MD, Akio Urabe, MD, Minoru Yoshida, MD, Akihisa Kanamaru, MD,PhD, Yoshihisa Kodera, MD, Shinichiro Okamoto, MD,PhD, Shigefumi Maesaki, MD, Tohru Masaoka, MD
Journal: Blood
Blood (2006) 108 (11): 2933.
https://doi.org/10.1182/blood.V108.11.2933.2933
Published: 2006